improve it or discuss these issues on the talk page . learn how and when to remove these template messages this article contains content that is written like an advertisement . please help improve it by removing promotional content and inappropriate external links and by adding encyclopedic content written from a neutral point of view . may 2014 learn how and when to remove this template message this article is an orphan as no other articles link to it . please introduce links to this page from related articles ; try the find link tool for suggestions . may 2014 this article contains wording that promotes the subject in a subjective manner without imparting real information . please remove or replace such wording and instead of making proclamations about a subject s importance use facts and attribution to demonstrate that importance . may 2014 learn how and when to remove this template message this article may rely excessively on sources too closely associated with the subject potentially preventing the article from being verifiable and neutral . please help improve it by replacing them with more appropriate citations to reliable independent third party sources . may 2014 learn how and when to remove this template message learn how and when to remove this template message molmed spa type public industry biotechnology founded 1996 headquarters milan italy key people claudio bordignon chairman and ceo products tk cell therapy ngr htnf antitumor recombinant protein revenue 6.714 2013 operating income 18.169 2013 number of employees 120 2013 website www.molmed.com molmed is a medical biotechnology company located in milan inside the san raffaele biomedical science park 1 which houses the san raffaele research hospital and scientific institute and a private university . the company was founded by claudio bordignon in 1996 as a joint venture between science park raf and boehringer mannheim 2 in order to create a cgmp structure specialised in the ex vivo manipulation of human cells for supplying gene and cell therapy services for clinical trial protocols . 3 molmed activities cover all functions from discovery to proof of clinical activity focuses on oncology indications that require new therapy options and has an in house gmp based manufacturing of cell and gene therapy products . molmed s product portfolio contains two therapeutic antitumour drugs undergoing clinical trial tk cell therapy product that permits bone marrow transplant from donors that are partially compatible with the patient in phase iii for the treatment of high risk leukaemia ; 4 ngr htnf antitumor recombinant protein 5 a recombinant biological drug that targets tumour blood vessels in phase iii in malignant pleural mesothelioma and in phase ii in six other indications colorectal liver and ovarian cancers small cell lung cancer non small cell lung cancer and in soft tissue sarcomas . molmed also provides high level competencies in gene and cell therapy for the development performance and validation of projects for third parties ; said competencies range from preclinical studies to phase iii clinical trials including the production in compliance with current gmp of viral vectors and patient specific genetically modified cells for clinical use . history edit molmed was founded in 1996 6 7 as a joint venture between science park raf and boehringer mannheim with the objective of creating a cutting edge cgmp structure specialized in the ex vivo manipulation of human cells for the supply of gene therapy services for clinical trial protocols . in the course of the first three years boehringer mannheim was acquired by roche which then sold its equity stake in molmed to the edcp venture capital fund . in 2000 molmed s corporate model changed the service company into a biopharmaceutical product company and the company developed further adding the operations typical of a biopharmaceutical development company to its service business with a focus on new therapies for the cure of cancer . 8 in fact in 2002 there was the acquisition and incorporation of genera s.p.a. the san raffaele scientific institute s research company . in 2004 there was the entrance of three important private italian investors in molmed fininvest herule finance today h equity s.r.l. and la leonardo finanziaria 9 today delfin s. r.l. . the company was listed on the milan stock exchange in 2008 10 with an ipo of 25 % of its shares resulting in 56 million euro gross proceeds . the total number of shares issued was 105 207 808 100 % ordinary shares with no par value . today total number of issued shares is 231 058 594 11 references edit biomedical science park raf sviluppo economico della provincia di milano . www.provincia.milano.it . molmed history . http www.molmed.com . external link in publisher help molmed san raffaele biomedical science park . http www.publiem.eu . external link in publisher help molmed clinical development update six abstracts accepted for presentation at asco 2012 . http www.marketwired.com . external link in publisher help molmed ngr htnf four studies accepted for presentation at asco 2013 . http ireport.cnn.com . external link in publisher help molmed likely to seek partner for cancer drug . http www.bloomberg.com . external link in publisher help claudio bordignon m.d. at mlm brsaitaliana . bloomberg . molmed company overview . the san raffaele biomedical science park . line feed character in publisher at position 28 help 4.2 billion euros appear in the cash . http www.milanofinanza.it . external link in publisher help molmed board of directors reviews 2007 financial statements . http www.evaluategroup.com . external link in publisher help shareholders information . www.molmed.com . external links edit official website retrieved from https en.wikipedia.org w index.php title molmed & oldid 727315773 categories companies established in 1996hidden categories cs1 errors external linkscs1 errors invisible charactersarticles with a promotional tone from may 2014all articles with a promotional toneorphaned articles from may 2014all orphaned articlesarticles with peacock terms from may 2014all articles with peacock termsarticles lacking reliable references from may 2014all articles lacking reliable references navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page print export create a bookdownload as pdfprintable version languages italiano edit links this page was last modified on 28 june 2016 at 05 00 . text is available under the creative commons attribution sharealike license ; additional terms may apply . by using this site you agree to the terms of use and privacy policy . wikipedia is a registered trademark of the wikimedia foundation inc. a non profit organization . privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view